128 related articles for article (PubMed ID: 36360276)
41. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
[TBL] [Abstract][Full Text] [Related]
42. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
43. Significant interpopulation differentiation at candidate loci may underlie ethnic disparities in the prevalence of uterine fibroids.
Dvornyk V
J Genet; 2021; 100():. PubMed ID: 34825663
[TBL] [Abstract][Full Text] [Related]
44. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.
Branković A; Brajušković G; Nikolić Z; Vukotić V; Cerović S; Savić-Pavićević D; Romac S
Int J Exp Pathol; 2013 Dec; 94(6):355-61. PubMed ID: 23998439
[TBL] [Abstract][Full Text] [Related]
45. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R
Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471
[TBL] [Abstract][Full Text] [Related]
46. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
47. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer.
Ianni M; Porcellini E; Carbone I; Potenzoni M; Pieri AM; Pastizzaro CD; Benecchi L; Licastro F
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):56-61. PubMed ID: 22850906
[TBL] [Abstract][Full Text] [Related]
48. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
Hoffmann TJ; Van Den Eeden SK; Sakoda LC; Jorgenson E; Habel LA; Graff RE; Passarelli MN; Cario CL; Emami NC; Chao CR; Ghai NR; Shan J; Ranatunga DK; Quesenberry CP; Aaronson D; Presti J; Wang Z; Berndt SI; Chanock SJ; McDonnell SK; French AJ; Schaid DJ; Thibodeau SN; Li Q; Freedman ML; Penney KL; Mucci LA; Haiman CA; Henderson BE; Seminara D; Kvale MN; Kwok PY; Schaefer C; Risch N; Witte JS
Cancer Discov; 2015 Aug; 5(8):878-91. PubMed ID: 26034056
[TBL] [Abstract][Full Text] [Related]
49. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
Kim ST; Cheng Y; Hsu FC; Jin T; Kader AK; Zheng SL; Isaacs WB; Xu J; Sun J
Prostate; 2010 Dec; 70(16):1729-38. PubMed ID: 20564319
[TBL] [Abstract][Full Text] [Related]
50. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
51. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
[TBL] [Abstract][Full Text] [Related]
52. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
53. Deciphering the Polygenic Basis of Racial Disparities in Prostate Cancer By an Integrative Analysis of Genomic and Transcriptomic Data.
Zhang W; Nicholson T; Zhang K
Cancer Prev Res (Phila); 2022 Mar; 15(3):161-171. PubMed ID: 34965922
[TBL] [Abstract][Full Text] [Related]
54. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Franco NR; Massi MC; Ieva F; Manzoni A; Paganoni AM; Zunino P; Veldeman L; Ost P; Fonteyne V; Talbot CJ; Rattay T; Webb A; Johnson K; Lambrecht M; Haustermans K; De Meerleer G; de Ruysscher D; Vanneste B; Van Limbergen E; Choudhury A; Elliott RM; Sperk E; Veldwijk MR; Herskind C; Avuzzi B; Noris Chiorda B; Valdagni R; Azria D; Farcy-Jacquet MP; Brengues M; Rosenstein BS; Stock RG; Vega A; Aguado-Barrera ME; Sosa-Fajardo P; Dunning AM; Fachal L; Kerns SL; Payne D; Chang-Claude J; Seibold P; West CML; Rancati T;
Radiother Oncol; 2021 Jun; 159():241-248. PubMed ID: 33838170
[TBL] [Abstract][Full Text] [Related]
55. Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.
Li J; Mercer E; Gou X; Lu YJ
Am J Cancer Res; 2013; 3(2):127-51. PubMed ID: 23593537
[TBL] [Abstract][Full Text] [Related]
56. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.
Van den Broeck T; Joniau S; Clinckemalie L; Helsen C; Prekovic S; Spans L; Tosco L; Van Poppel H; Claessens F
Biomed Res Int; 2014; 2014():627510. PubMed ID: 24701578
[TBL] [Abstract][Full Text] [Related]
57. Single nucleotide polymorphism within chromosome 8q24 is associated with prostate cancer development in Saudi Arabia.
Osman AE; Alharbi S; Ahmed AA; Elbagir AA
Asian J Urol; 2024 Jan; 11(1):26-32. PubMed ID: 38312824
[TBL] [Abstract][Full Text] [Related]
58. Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approach.
Jacobs DI; Walsh KM; Wrensch M; Wiencke J; Jenkins R; Houlston RS; Bondy M; Simon M; Sanson M; Gousias K; Schramm J; Labussière M; Di Stefano AL; Wichmann HE; Müller-Nurasyid M; Schreiber S; Franke A; Moebus S; Eisele L; Dewan AT; Dubrow R
Front Genet; 2012; 3():203. PubMed ID: 23091480
[TBL] [Abstract][Full Text] [Related]
59. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of
Tian Y; Dong D; Wang Z; Wu L; Park JY; Wei GH; Wang L;
bioRxiv; 2023 May; ():. PubMed ID: 36711639
[TBL] [Abstract][Full Text] [Related]
60. A review of studies examining the association between genetic biomarkers (short tandem repeats and single-nucleotide polymorphisms) and risk of prostate cancer: the need for valid predictive biomarkers.
Albujja MH; Vasudevan R; Alghamdi S; Pei CP; Bin Mohd Ghani KA; Ranneh Y; Ismail PB
Prostate Int; 2020 Dec; 8(4):135-145. PubMed ID: 33425790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
